![]() |
Custom Search
|
NEW YORK (Reuters Health) - Use of cholesterol-lowering statin drugs, especially long-term use, appears to raise the risk of prostate cancer among obese men, according to findings of a new study. In a population-based, case-control study, the ... Read the entire article at National Library of Medicine | ||||
|